These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Optimized synthesis of O-carboxymethyl-N,N,N-trimethyl chitosan. Patrulea V; Applegate LA; Ostafe V; Jordan O; Borchard G Carbohydr Polym; 2015 May; 122():46-52. PubMed ID: 25817641 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization and in vitro biological properties of O-methyl free N,N,N-trimethylated chitosan. Verheul RJ; Amidi M; van der Wal S; van Riet E; Jiskoot W; Hennink WE Biomaterials; 2008 Sep; 29(27):3642-3649. PubMed ID: 18556059 [TBL] [Abstract][Full Text] [Related]
25. Thiolated trimethyl chitosan nanocomplexes as gene carriers with high in vitro and in vivo transfection efficiency. Zhao X; Yin L; Ding J; Tang C; Gu S; Yin C; Mao Y J Control Release; 2010 May; 144(1):46-54. PubMed ID: 20093155 [TBL] [Abstract][Full Text] [Related]
26. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. Park K; Kim JH; Nam YS; Lee S; Nam HY; Kim K; Park JH; Kim IS; Choi K; Kim SY; Kwon IC J Control Release; 2007 Oct; 122(3):305-14. PubMed ID: 17643545 [TBL] [Abstract][Full Text] [Related]
27. Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers. He W; Guo X; Xiao L; Feng M Int J Pharm; 2009 Dec; 382(1-2):234-43. PubMed ID: 19686826 [TBL] [Abstract][Full Text] [Related]
28. Chitosan and its salts for mucosal and transmucosal delivery. Bonferoni MC; Sandri G; Rossi S; Ferrari F; Caramella C Expert Opin Drug Deliv; 2009 Sep; 6(9):923-39. PubMed ID: 19637983 [TBL] [Abstract][Full Text] [Related]
29. Methylated N-(4-pyridinylmethyl) chitosan as a novel effective safe gene carrier. Opanasopit P; Sajomsang W; Ruktanonchai U; Mayen V; Rojanarata T; Ngawhirunpat T Int J Pharm; 2008 Nov; 364(1):127-34. PubMed ID: 18775484 [TBL] [Abstract][Full Text] [Related]
30. Transdermal permeation enhancement of N-trimethyl chitosan for testosterone. He W; Guo X; Zhang M Int J Pharm; 2008 May; 356(1-2):82-7. PubMed ID: 18337030 [TBL] [Abstract][Full Text] [Related]
31. Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods. Sadeghi AM; Dorkoosh FA; Avadi MR; Saadat P; Rafiee-Tehrani M; Junginger HE Int J Pharm; 2008 May; 355(1-2):299-306. PubMed ID: 18206322 [TBL] [Abstract][Full Text] [Related]
32. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606 [TBL] [Abstract][Full Text] [Related]
33. Water soluble complexes of chitosan-g-MPEG and hyaluronic acid. Wu J; Wang X; Keum JK; Zhou H; Gelfer M; Avila-Orta CA; Pan H; Chen W; Chiao SM; Hsiao BS; Chu B J Biomed Mater Res A; 2007 Mar; 80(4):800-12. PubMed ID: 17058210 [TBL] [Abstract][Full Text] [Related]
34. Trimethyl chitosan and its applications in drug delivery. Mourya VK; Inamdar NN J Mater Sci Mater Med; 2009 May; 20(5):1057-79. PubMed ID: 19112609 [TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery. Chen F; Zhang ZR; Yuan F; Qin X; Wang M; Huang Y Int J Pharm; 2008 Feb; 349(1-2):226-33. PubMed ID: 17825506 [TBL] [Abstract][Full Text] [Related]
36. Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro. Germershaus O; Mao S; Sitterberg J; Bakowsky U; Kissel T J Control Release; 2008 Jan; 125(2):145-54. PubMed ID: 18023906 [TBL] [Abstract][Full Text] [Related]
38. [The effect of the degree of deacetylation of chitosan on the biocompatibility of chitosan membrane with corneal stromal cells]. Yao Z; Wu H; Han B; Liu W Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Aug; 23(4):800-4. PubMed ID: 17002111 [TBL] [Abstract][Full Text] [Related]
39. Trimethyl and carboxymethyl chitosan carriers for bio-active polymer-inorganic nanocomposites. Geisberger G; Gyenge EB; Maake C; Patzke GR Carbohydr Polym; 2013 Jan; 91(1):58-67. PubMed ID: 23044105 [TBL] [Abstract][Full Text] [Related]
40. Antibacterial activity of quaternary ammonium chitosan containing mono or disaccharide moieties: preparation and characterization. Sajomsang W; Gonil P; Tantayanon S Int J Biol Macromol; 2009 Jun; 44(5):419-27. PubMed ID: 19428476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]